Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Syndrome

3,3',5-triiodothyroacetic acid has been researched along with Syndrome in 3 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Syndrome: A characteristic symptom complex.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ZONDEK, H1
LESZYNSKY, HE1
ZONDEK, GW1
Messier, N1
Laflamme, L1
Hamann, G1
Langlois, MF1
Hughes, IA1
Ichikawa, K1
Degroot, LJ1
John, R1
Jones, MK1
Hall, R1
Scanlon, MF1

Other Studies

3 other studies available for 3,3',5-triiodothyroacetic acid and Syndrome

ArticleYear
Triac stosstherapy in sporadic goitrous cretinism.
    British medical journal, 1959, Feb-07, Volume: 1, Issue:5118

    Topics: Abnormalities, Multiple; Congenital Hypothyroidism; Humans; Minerals; Syndrome; Triiodothyronine

1959
In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy.
    Molecular and cellular endocrinology, 2001, Mar-28, Volume: 174, Issue:1-2

    Topics: Dose-Response Relationship, Drug; Drug Resistance; Genes, Reporter; Humans; Inhibitory Concentration

2001
Non-adenomatous inappropriate TSH hypersecretion and euthyroidism requires no treatment.
    Clinical endocrinology, 1987, Volume: 27, Issue:4

    Topics: Child, Preschool; Female; Fibroblasts; Goiter; Humans; Male; Middle Aged; Pituitary Function Tests;

1987